# CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)

> **NCT02184117** · — · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 763 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Adenosine
- **DRUG:** Contrast Media
- **DRUG:** Resting conditions

## Key facts

- **NCT ID:** NCT02184117
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 763 (ACTUAL)
- **Last updated:** 2016-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02184117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02184117, "CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02184117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*